ginkgolide b has been researched along with Ischemic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Han, Y; Hu, J; Jin, Z; Kong, L; Luo, J; Yang, L; Yu, P; Zhang, C; Zhao, C; Zhu, J | 1 |
| Ataullakhanov, FI; Guan, X; Han, Q; Ke, Y; Liu, L; Ma, Z; Panteleev, M; Shi, Q; Xia, Y; Xiang, Z; Ye, H; Zhang, T | 1 |
2 other study(ies) available for ginkgolide b and Ischemic Stroke
| Article | Year |
|---|---|
Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice.
Topics: Animals; Brain Ischemia; Creatine Kinase; Endothelial Cells; Ginkgolides; Infarction, Middle Cerebral Artery; Ischemic Stroke; Lactones; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Stroke | 2022 |
Thrombus Inhibition and Neuroprotection for Ischemic Stroke Treatment through Platelet Regulation and ROS Scavenging.
Topics: Humans; Ischemic Stroke; Manganese Compounds; Neuroprotection; Oxides; Reactive Oxygen Species; Thrombosis | 2022 |